Edgewise Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.66 billion, with shareholders equity totaling $448.08 million.
The company employs approximately 19 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Edgewise Therapeutics Inc. reported $- in revenue, generating net income of $-197.23 million.
Key financial metrics include a P/E ratio of -23.65, a price-to-book (P/B) ratio of 10.41, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker EWTX.